Medibank Private to list on the ASX?

A surprise windfall could be in the cards for policy holders.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The sale of government owned health insurer Medibank Private has been in the cards for the better part of a decade. It has finally made its way to reality, where the Abbott government is looking to raise around $4 billion from the sale. News Limited reported last week that the government was considering a variety of sale options, including a public float on the Australian Stock Exchange.

An issue of free 'compensatory shares' to existing policy holders is also being considered, similar to shares handed out by health insurer NIB Holdings (ASX: NHF) when it first listed on the ASX in 2007. If it goes ahead this will be good news for policy holders, who will effectively own part of the nation's largest health insurer, as well as being indirectly compensated (via dividends) for the profit Medibank earns on their own insurance policies. Medibank Private holds approximately 30% of the national health insurance market, compared to international giant BUPA's 27% and NIB's comparatively small 7%.

If it does list on the ASX, Medibank Private will be one of the biggest IPOs in recent years and provides an excellent opportunity to potential investors. As fellow Motley Fool contributor Tim McArthur notes, government shares generally provide solid, reliable returns to investors. Partly this is due to the wide range of customers they serve, and also due to the core nature of the services they provide.

Companies such as Aurizon (ASX: AZJ) (formerly Queensland Rail) and Commonwealth Bank (ASX: CBA) were vital parts of the Australian economy when they were government owned; Medibank Private is one of the last giant corporations (alongside Australia Post) that is still in government hands.

Foolish takeaway

Incidentally, Medibank Private is already running as an at-profit business since Kevin Rudd overhauled the insurer back in 2009. Privatisation is not expected to result in premiums growing faster than the market rate.

I sincerely hope that Medibank does list on the ASX; depending on a number of factors (such as listing price), it could present an excellent opportunity to investors. Some investors are averse to IPOs because the shares are often available on market cheaper than they are at launch; however this is one potential IPO I would recommend investors watch out for.

Motley Fool contributor Sean O’Neill doesn’t own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »